NIH Funding Opportunities

• Screening, Brief Intervention and Referral to Treatment or Prevention (SBIRT/P) for alcohol, tobacco, and other drugs (ATOD) use and misuse in adult populations that experience health disparities (R01, Clinical Trial Required) November 21, 2024
  Funding Opportunity PAR-26-001 from the NIH Guide for Grants and Contracts. The Office of Disease Prevention (ODP) and participating National Institutes of Health (NIH) Institutes, Centers, and Offices (ICOs) are issuing this notice of funding opportunity (NOFO) seeking applications to test innovative approaches to implementing SBIRT/P for alcohol, tobacco, and other drugs (ATOD) use and […]
• Reminder that Multiple Changes Affecting Extramural Applications and Review are Coming for Application Due Dates on or After January 25, 2025 November 21, 2024
  Notice NOT-OD-25-035 from the NIH Guide for Grants and Contracts
• Notice of Special Interest (NOSI): Advancing Research Needed to Develop a Universal Influenza Vaccine November 21, 2024
  Notice NOT-AI-24-081 from the NIH Guide for Grants and Contracts
• Notice of Intent to Publish a Funding Opportunity Announcement for NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Underserved Racial and/or Ethnic Populations (R01) November 21, 2024
  Notice NOT-DA-24-052 from the NIH Guide for Grants and Contracts
• Notice of Intent to Publish a Funding Opportunity Announcement for NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Underserved Racial and/or Ethnic Populations (R34) November 21, 2024
  Notice NOT-DA-24-051 from the NIH Guide for Grants and Contracts
• Notice of Intent to Publish a Funding Opportunity Announcement for NINR Areas of Emphasis for Research to Optimize Health for All (R21 Clinical Trial Optional) November 21, 2024
  Notice NOT-NR-25-007 from the NIH Guide for Grants and Contracts
• Notice of Intent to Publish a Funding Opportunity Announcement for NINR Areas of Emphasis for Research to Optimize Health for All (R01 Clinical Trial Optional) November 21, 2024
  Notice NOT-NR-25-006 from the NIH Guide for Grants and Contracts
• Building in vivo Preclinical Assays of Circuit Engagement for Application in Therapeutic Development (R01 Clinical Trial Not Allowed) November 21, 2024
  Funding Opportunity PAR-25-035 from the NIH Guide for Grants and Contracts. SRF Reissue: The overall goal of this notice of funding opportunity (NOFO) is to identify, in animals, in vivo neurophysiological and behavioral measures for use as assays in the early screening phase of treatment development. The NOFO will support efforts to optimize and evaluate […]
• Novel Assays to Address Translational Gaps in Treatment Development (UG3/UH3 Clinical Trial Optional) November 21, 2024
  Funding Opportunity PAR-25-034 from the NIH Guide for Grants and Contracts. SRF Reissue: The overall goal of this initiative is to identify neurophysiological measures potential assays for treatment development research. The Notice of Funding Opportunity (NOFO) will support efforts to optimize and evaluate measures of neurophysiological processes that are disrupted within or across mental disorders […]
• Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required) November 21, 2024
  Funding Opportunity PAR-25-148 from the NIH Guide for Grants and Contracts. The purpose of this Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions is to support small scale research grants at institutions that do not receive substantial funding from the NIH, with an emphasis on providing biomedical research experiences primarily for undergraduate students and enhancing […]